This inventor holds 1 USPTO granted patent. Top assignee: Gyogyszerkutato Intezet Kft.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Tam As H Amori: Innovator in Pharmaceutical Compositions
Introduction
Tam As H Amori is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on N-acyl-2,3-benzodiazepine derivatives. His research focuses on developing compounds that have valuable effects on the central nervous system.
Latest Patents
Tam As H Amori holds 1 patent for his invention titled "N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions." This invention relates to novel N-acyl-2,3-benzodiazepine derivatives of the general formula (I), their stereoisomers, and acid-addition salts. The pharmaceutical compositions containing these compounds are designed for the treatment of various diseases originating from the central nervous system. The compounds exhibit muscle-relaxant, anticonvulsive, and neuroprotective actions, making them valuable in medical applications.
Career Highlights
Tam As H Amori is associated with Gyogyszerkutato Intezet Kft., where he continues to advance his research in pharmaceutical sciences. His work has contributed to the understanding and development of new therapeutic options for patients with central nervous system disorders.
Collaborations
Throughout his career, Tam has collaborated with notable colleagues, including Ferenc Andr Asi and P Al Berzsenyi. These partnerships have fostered a collaborative environment that enhances the innovation process in their research endeavors.
Conclusion
Tam As H Amori is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the treatment of central nervous system diseases significantly. His innovative approach and dedication to research continue to pave the way for advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile